Metropolitan Life Insurance Company (MetLife)’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,949
| Closed | -$156K | – | 233 |
|
|
2024
Q1 | $156K | Sell |
1,949
-93
| -5% | -$7.42K | 0.01% | 816 |
|
|
2023
Q4 | $163K | Hold |
2,042
| – | – | 0.01% | 838 |
|
|
2023
Q3 | $143K | Buy |
2,042
+264
| +15% | +$18.5K | 0.01% | 836 |
|
|
2023
Q2 | $128K | Hold |
1,778
| – | – | 0.01% | 890 |
|
|
2023
Q1 | $110K | Sell |
1,778
-203
| -10% | -$12.5K | 0.01% | 949 |
|
|
2022
Q4 | $153K | Buy |
1,981
+258
| +15% | +$19.9K | 0.01% | 836 |
|
|
2022
Q3 | $76.9K | Sell |
1,723
-186
| -10% | -$8.3K | ﹤0.01% | 1172 |
|
|
2022
Q2 | $73.1K | Hold |
1,909
| – | – | ﹤0.01% | 1257 |
|
|
2022
Q1 | $79K | Sell |
1,909
-6,439
| -77% | -$267K | ﹤0.01% | 1352 |
|
|
2021
Q4 | $315K | Hold |
8,348
| – | – | ﹤0.01% | 1714 |
|
|
2021
Q3 | $275K | Hold |
8,348
| – | – | ﹤0.01% | 1838 |
|
|
2021
Q2 | $563K | Buy |
8,348
+346
| +4% | +$23.3K | 0.01% | 1450 |
|
|
2021
Q1 | $453K | Sell |
8,002
-223
| -3% | -$12.6K | 0.01% | 1486 |
|
|
2020
Q4 | $670K | Hold |
8,225
| – | – | 0.01% | 1171 |
|
|
2020
Q3 | $586K | Hold |
8,225
| – | – | 0.01% | 1104 |
|
|
2020
Q2 | $677K | Hold |
8,225
| – | – | 0.01% | 1004 |
|
|
2020
Q1 | $484K | Buy |
8,225
+598
| +8% | +$35.2K | 0.01% | 1065 |
|
|
2019
Q4 | $788K | Sell |
7,627
-836
| -10% | -$86.4K | 0.01% | 1044 |
|
|
2019
Q3 | $171K | Buy |
8,463
+6,617
| +358% | +$134K | ﹤0.01% | 1988 |
|
|
2019
Q2 | $47.5K | Buy |
+1,846
| New | +$47.5K | ﹤0.01% | 2510 |
|